- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
An Esmya-linked meeting invitation was deemed promotional due to brand imagery and content, but lacked prescribing information (breach Clause 4.1). Allegations of…
Anonymous GP alleged a Boehringer Ingelheim rep said Spiriva Respimat was “perfectly safe” based on an unpublished study. Panel found the allegation…
Sanofi’s Lyxumia materials claimed it was the “only once-daily prandial GLP‑1”, plus broad benefit and “strong evidence” statements. PMCPA ruled the claims…
Anonymous GP challenged two ad claims for Relvar Ellipta (“Delivered in a straightforward device” and “That offers value to the NHS”). PMCPA…
A Pulse Quick Guide funded by Bausch & Lomb described Emerade as offering a “new higher dose” even though the 500mcg dose…
A CCG complained about a third‑party webinar invite for Sayana Press. Panel found the email’s promotional nature was disguised and Pfizer’s sponsorship…
A UCB medical information email about Keppra vs generic levetiracetam appeared on the ESNA nurses’ website without attribution. Panel accepted it was…
A congress-stand presentation included a dosing/missed-dose graph that wasn’t clearly labelled as simulated or properly attributed. The Panel found it misleading (Clauses…
A Germany-sent LinkedIn InMail promoting Giotrif reached UK recipients. It lacked UK certification, prescribing info, AE reporting and black triangle, used unbalanced/misleading…
A clinician challenged BuTrans dementia-focused promotion. PMCPA ruled website/detail aid misleading and unsubstantiated for analgesic efficacy and implied antipsychotic reduction; BMJ ad…
NHS employee alleged GP practices were misled that a ProStrakan-sponsored osteoporosis therapy review (via a third party) was CCG-approved/continuation of a prior…
Public complaint about clinical trial transparency data for Ilaris and Gilenya. PMCPA found one Ilaris trial result was disclosed late (breach Clauses…
Anonymous complaint alleged MSD funded speakers and effectively ran a diabetes nurses study day without clear disclosure. Panel found no evidence, confirmed…
Complaint about Napp’s ORCA asthma therapy review and a Remsima advisory board. ORCA allegations not proven (no breach). Advisory board ruled not…
At a Sunovion-organised ‘HOPE’ meeting, a company presenter was found (on balance of probabilities) to have suggested clinicians should feel guilty prescribing…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.